KCNAB1 (Kv beta 1) Antibody (YA8362)
(Synonyms: AKR6A3; hKvb3; hKvBeta3; KCNA1B; KV-BETA-1; Kvb1.3)KCNAB1 (Kv beta 1) Antibody (YA8362) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to KCNAB1 (Kv beta 1).
-
Host:
Mouse
-
Isotype:
IgG
-
Application:
IHC-P, ICC/IF, FC
-
Reactivity :
Human, Mouse, Rat
-
Formulation:
Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
-
Conjugation:
Non-conjugated
Applications
| Application |
IHC-P
IHC-P: Immunohistochemistry-Paraffin
|
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
FC
FC: Flow Cytometry
|
|---|---|---|---|
| Dilution Ratio | 1:150-500 | 1:100-250 | 1:100 |
Product Details
KCNAB1 (Kv beta 1) Antibody (YA8362) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to KCNAB1 (Kv beta 1).
-
Host Mouse
-
Clonality Monoclonal
-
Species ReactivityHuman, Mouse, Rat
-
Calculated Molecular Weight Predicted band size: 44.5 kDa
Full length human recombinant protein of human KCNAB1 produced in HEK293T cell.
Endogenous
Affinity purified
Non-conjugated
Unmodified
IgG
Product Properties
-
Appearance
Solution
-
Formulation
Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Background
-
Function
KCNAB1 is a Regulatory subunit of the voltage-gated potassium (Kv) Shaker channels composed of pore-forming and potassium-conducting alpha subunits and of regulatory beta subunits. The beta-1/KCNAB1 cytoplasmic subunit mediates closure of delayed rectifier potassium channels by physically obstructing the pore via its N-terminal domain and increases the speed of channel closure for other family members. Promotes the inactivation of Kv1.1/KCNA1, Kv1.2/KCNA2, Kv1.4/KCNA4, Kv1.5/KCNA5 and Kv1.6/KCNA6 alpha subunit-containing channels. Displays nicotinamide adenine dinucleotide phosphate (NADPH)-dependent aldoketoreductase activity by catalyzing the NADPH-dependent reduction of a variety of endogenous aldehydes and ketones. The binding of NADPH is required for efficient down-regulation of potassium channel activity. Oxidation of the bound NADPH restrains N-terminal domain from blocking the channel, thereby decreasing N-type inactivation of potassium channel activity|Isoform KvB1.2 shows no effect on KCNA1, KCNA2 or KCNB1[1][2][3][4][5][6][7][8][9][10][11].
-
Subcellular Localization
Cytoplasm,Membrane,Cell membrane
-
Expression
Tissue_Specificity: In brain, expression is most prominent in caudate nucleus, hippocampus and thalamus. Significant expression also detected in amygdala and subthalamic nucleus. Also expressed in both healthy and cardiomyopathic heart. Up to four times more abundant in left ventricle than left atrium -
Isoforms & Post-Translational Modification
Q14722 has three isomers: Q14722-1: 46563 Da (predicted); Q14722-2: 44710 Da (predicted); Q14722-3: 45492 Da (predicted).
-
Subunit
Homotetramer (By similarity)
-
SwissProt ID
-
Synonyms
AKR6A3; hKvb3; hKvBeta3; KCNA1B; KV-BETA-1; Kvb1.3
Documentation